# Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT

> **NCT02302768** · PHASE2 · UNKNOWN · sponsor: **University of Siena** · enrollment: 60 (actual)

## Conditions studied

- Thyroiditis Autoimmune

## Interventions

- **DIETARY_SUPPLEMENT:** Selenomethionine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02302768
- **Lead sponsor:** University of Siena
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2014-01
- **Final completion:** 2015-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302768, "Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02302768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*